Biomind Labs Statistics

Total Valuation

Biomind Labs has a market cap or net worth of CAD 33.32 million. The enterprise value is 34.54 million.

Market Cap	33.32M
Enterprise Value	34.54M

Important Dates

The next estimated earnings date is Monday, March 31, 2025.

Earnings Date	Mar 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.91%
Shares Change (QoQ)	+3.62%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-36.28
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.02

Current Ratio	0.02
Quick Ratio	0.01
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.05

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-238.02%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +200.00% in the last 52 weeks. The beta is -0.00, so Biomind Labs's price volatility has been lower than the market average.

Beta (5Y)	-0.00
52-Week Price Change	+200.00%
50-Day Moving Average	0.45
200-Day Moving Average	0.45
Relative Strength Index (RSI)	45.28
Average Volume (20 Days)	7,692

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.14

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-543,697
Pretax Income	-952,148
Net Income	-952,148
EBITDA	-546,088
EBIT	-543,697
Earnings Per Share (EPS)	-0.01

Full Income Statement

Balance Sheet

The company has 13,668 in cash and 1.19 million in debt, giving a net cash position of -1.18 million.

Cash & Cash Equivalents	13,668
Total Debt	1.19M
Net Cash	-1.18M
Net Cash Per Share	n/a
Equity (Book Value)	-2.06M
Book Value Per Share	-0.03
Working Capital	-2.09M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-623,880
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Biomind Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.91%
Shareholder Yield	-0.91%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a